View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Bella Lu Yifei ... (+20)
  • Bella Lu Yifei
  • Benjaphol Suthwanish
  • Colin Lee
  • Desmond Chong Chee Wai
  • Ejann Hiew
  • Heidi Mo Jinghui
  • Jo Yee Ng
  • John Cheong Ming Chern
  • Johnny Yum Chung Man
  • Jonathan Koh
  • Kasemsun Koonnara
  • Keith Wee Teck Keong
  • Ken Lee
  • Kenny Yong Hui Lim
  • Malaysia Research Team
  • Posmarito Pakpahan
  • Shirley Wang Xueyi
  • Stella Guo Yuting
  • Vincent Khoo Boo Aik
  • Willinoy Sitorus

Regional Morning Notes - Friday, May 02, 2025

GREATER CHINA Sector Macau Gaming: Apr 25 GGR beat expectations; May Day Golden Week visitor arrivals expected to grow 4% yoy. Results ASMPT (522 HK/BUY/HK$52.20/Target: HK$68.00): 1Q25: Earnings disappoint; mainstream tools recovering in 2025 but visibility remains low. Maintain BUY. China Tourism Group Duty Free (601888 CH/BUY/Rmb63.40/Target: Rmb70.80): 1Q25: Core net profit down 16% yoy; sequential improvement in Hainan duty-free sales. Ganfeng Lithium (1772 HK/BUY/HK$18.94/Target: HK$30.00)...

Benjaphol Suthwanish
  • Benjaphol Suthwanish

Bumrungrad Hospital (BH TB) - Less Optimistic On Foreign Patient Numbe...

The tone at BH’s 1Q25 analyst meeting was negative. Management still does not expect a rebound in hospital revenue as a result of the earthquake in Mar 25. The drop in revenue intensity in 1Q25 could become a concern if it becomes a recurring trend. Despite the positive development in Saudi Arabia and Bangladesh, we are less optimistic on BH as it lacks a substantial catalyst to improve its earnings. Downgrade to HOLD. Target price: Bt178.00.

Benjaphol Suthwanish ... (+2)
  • Benjaphol Suthwanish
  • Kasemsun Koonnara

Thailand Daily - Friday, May 02, 2025

KEY HIGHLIGHTS Sector Property 1Q25 earnings under pressure; recovery outlook remains uncertain. Update Asset World Corporation (AWC TB/BUY/Bt2.20/Target: Bt3.30) Expect strong earnings growth in 1Q25. Bumrungrad Hospital (BH TB/HOLD/Bt168.50/Target: Bt178.00) Less optimistic on foreign patient numbers. Downgrade to HOLD. Siam Cement (SCC TB/HOLD/Bt160.00/Target: Bt160.00) Timeline for the LSP project to resume operations remains uncertain.

Benjaphol Suthwanish
  • Benjaphol Suthwanish

Bumrungrad Hospital (BH TB) - 1Q25: Weak Results In Line With Expectat...

BH reported a net profit of Bt1.73b (-12.6% yoy, -8.9% qoq) in 1Q25, which is in line with our and consensus estimates. The high base last year and the earlier timing of Ramadan this year caused top-line to drop by 6.1% yoy. Growth in revenue from Thai patients was weak at 1.3% yoy and was not sufficient to compensate for the shortfall in foreign patient revenue. We are more optimistic about BH’s 2Q25 outlook as the impact from Ramadan was already realised in 1Q25. Maintain BUY. Target pric...

Benjaphol Suthwanish ... (+3)
  • Benjaphol Suthwanish
  • Kampon Akaravarinchai
  • Thanawat Thangchadakorn

Thailand Daily - Friday, April 25, 2025

KEY HIGHLIGHTS Sector Banking 1Q25: Results beat; banks prioritise less on loan growth. Downgrade to MARKET WEIGHT. Results Bumrungrad Hospital (BH TB/BUY/Bt169.00/Target: Bt232.00) 1Q25: Weak results in line with expectations. Update Thai Foods Group (TFG TB/BUY/Bt5.05/Target: Bt6.70) Expect record-high earnings in 1Q25 and 2Q25. Thanachart Capital (TCAP TB/HOLD/Bt47.00/Target: Bt48....

Adrian Loh Tzum Yung ... (+14)
  • Adrian Loh Tzum Yung
  • Bella Lu Yifei
  • Benjaphol Suthwanish
  • Carol Dou Xiao Qin
  • Jack Goh Tooan Orng
  • Jonathan Koh
  • Julia Pan Mengyao
  • Kampon Akaravarinchai
  • Ken Lee
  • Ming San Soong
  • Paula Ruth
  • Posmarito Pakpahan
  • Sunny Chen
  • Thanawat Thangchadakorn

Regional Morning Meeting Notes: Friday, April 25, 2025

GREATER CHINA Results Aier Eye Hospital Group (300015 CH/BUY/Rmb12.72/Target: Rmb17.80) 2024: Satisfactory results; expects strong recovery in 2025. Upgrade to BUY. Ningbo Tuopu Group Co (601689 CH/BUY/Rmb50.96/Target: Rmb83.00) 4Q24: Earnings up 38.5% yoy, in line. Maintain BUY with target price unchanged at Rmb83.00. TAL Educational Group (TAL US/BUY/US$9.36/Target: US$14.00) 4QFY25: Earnings miss amid ramped-up investments in AI-powered learning. INDONESIA Sector Telecommun...

Benjaphol Suthwanish
  • Benjaphol Suthwanish

Bumrungrad Hospital (BH TB) - Expect Weak 1Q25 Earnings Due To Margin ...

We expect BH to report a net profit of Bt1.7b in 1Q25 (-13.2% yoy, -9.4% qoq). Top-line should be weak at Bt6.1b (-6.5% yoy, -5.6% qoq) due to the high base last year and the earlier timing of Ramadan this year. As a result, the expected decrease in Middle Eastern patient volume should also lead to a yoy margin contraction. We expect the 2Q25 outlook to improve, as a yoy growth will come off a more normalised base in 2Q24. Maintain BUY. Target price: Bt232.00.

Benjaphol Suthwanish ... (+2)
  • Benjaphol Suthwanish
  • Thanawat Thangchadakorn

Thailand Daily - Friday, April 18, 2025

KEY HIGHLIGHTS Results Bangkok Bank (BBL TB/HOLD/Bt146.50/Target: Bt154.00) 1Q25: Results beat expectations; investment gain boosted the bottom line. TISCO Financial Group (TISCO TB/HOLD/Bt100.00/Target: Bt94.00) 1Q25: Results in line; revises down 2025 credit cost target to 100bp. Update Bumrungrad Hospital (BH TB/BUY/Bt168.00/Target: Bt232.00) Expect weak 1Q25 earnings due to margin pressure.

Benjaphol Suthwanish
  • Benjaphol Suthwanish

Bumrungrad Hospital (BH TB) - Outlook For Foreign Patients Remains Und...

We attended BH’s 4Q24 analyst meeting and the tone was neutral. The strong growth of Thai patients in 4Q24 was attributable to the health checkup season. There have been favourable developments in Middle Eastern countries like Kuwait and Saudi Arabia but a definite timeline is still lacking. We believe that earnings growth in 1Q25 will be challenging due to the shortfall in Kuwait. However, we expect to see a gradual improvement from 2Q25 onwards. Maintain BUY. Target price: Bt232.00.

Benjaphol Suthwanish ... (+2)
  • Benjaphol Suthwanish
  • Kasemsun Koonnara

Thailand Daily - Thursday, March 06, 2025

Update Bumrungrad Hospital (BH TB/BUY/Bt195.50/Target: Bt232.00) Outlook for foreign patients remains under observation. Origin Property (ORI TB/HOLD/Bt2.68/Target: Bt2.90) Conservative 2025 business plan focusing on financial stability. Stecon Group (STECON TB/BUY/Bt5.40/Target: Bt6.50) Overhang clears; earnings recovery in sight

Adrian Loh Tzum Yung ... (+11)
  • Adrian Loh Tzum Yung
  • Benjaphol Suthwanish
  • Claire Wang Kelai
  • Desmond Chong Chee Wai
  • Guan An Tan
  • Jonathan Koh
  • Kasemsun Koonnara
  • Kong Ho Meng
  • Posmarito Pakpahan
  • Roy Chen Chengzhi
  • Tham Mun Hon

Regional Morning Notes - Thursday, March 06, 2025

GREATER CHINA Economics Highlights From The NPC: A comprehensive response to economic challenges. Update Cathay Pacific Airways (293 HK/HOLD/HK$10.76/Target: HK$11.30): Cathay’s stellar 2024 earnings performance is unlikely to be sustainable in the long run, but a potential beat of street estimates may still provide a near-term trading opportunity. INDONESIA Update Bank Rakyat Indonesia (BBRI IJ/BUY/Rp3,840/Target: Rp4,500): Spike in CoC in 1Q25; focus on cleaning up loans. MALAYSIA Sector Tec...

Benjaphol Suthwanish
  • Benjaphol Suthwanish

Bumrungrad Hospital (BH TB) - 4Q24: Strong 4Q24 Earnings Attributable ...

BH reported a net profit of Bt1.9b in 4Q24 (+10.6% yoy, -2.7% qoq), above our expectations but in line with consensus’. The strong earnings were mainly contributed by the utilisation of tax benefit in the quarter. Top-line came in at Bt6.5b, down slightly yoy due to the continuous drop in foreign patient revenue, partly offset by the strong growth of Thai patients. We expect to see slight growth in 1Q25 with a mixed outlook. Maintain BUY. Target price: Bt232.00.

Arsit Pamaranont ... (+5)
  • Arsit Pamaranont
  • Benjaphol Suthwanish
  • Kampon Akaravarinchai
  • Kasemsun Koonnara
  • Kitpon Praipaisarnkit

tHAILAND Daily: Friday, February 28, 2025

Results Amata Corporation (AMATA TB/BUY/Bt23.90/Target: Bt35.00) 4Q24: Net income misses expectations but still robust yoy and qoq. AP Thailand (AP TB/BUY/Bt8.70/Target: Bt11.30) 4Q24: Earnings in line; aggressive strategy for 2025. Bumrungrad Hospital (BH TB/BUY/Bt183.50/Target: Bt232.00) 4Q24: Strong 4Q24 earnings attributable to tax benefit. Hana Microelectronics (HANA TB/HOLD/Bt20.10/Target: Bt22.00) 4Q24: Net loss from high impairment. Indorama Ventures (IVL TB/BUY/Bt19.30/Target: Bt30.00)...

Adrian Loh Tzum Yung ... (+24)
  • Adrian Loh Tzum Yung
  • Bella Lu Yifei
  • Benjaphol Suthwanish
  • Carol Dou Xiao Qin
  • Damon Shen
  • Ejann Hiew
  • Gigi Cheuk
  • Jack Goh Tooan Orng
  • Jieqi Liu
  • John Cheong Ming Chern
  • Kasemsun Koonnara
  • Kate Luang
  • Keith Wee Teck Keong
  • Ken Lee
  • Kenny Yong Hui Lim
  • Lester Siew
  • Llelleythan Tan Tan
  • Philip Wong
  • Posmarito Pakpahan
  • Roy Chen Chengzhi
  • Shirley Wang Xueyi
  • Stella Guo Yuting
  • Sunny Chen
  • Tanaporn Visaruthaphong

Regional Morning Meeting Notes: Friday, February 28, 2025

GREATER CHINA Sector Automobile Weekly: PV sales picked up wow while the wait-and-see sentiment continues. Upgrade Li Auto and XPeng from HOLD to BUY and raise target price to HK$156.00 and HK$110.00 respectively. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely, CATL, Fuyao and Desay. Results BeiGene (6160 HK/BUY/HK$161.60/Target: HK$220.00) 2024: Results beat; targets operating profit...

Benjaphol Suthwanish
  • Benjaphol Suthwanish

Bumrungrad Hospital (BH TB) - Weak 4Q24 Earnings Expected

BH should report a net profit of Bt1.7b in 4Q24 (-1.3% yoy, -13.1% qoq). The earnings should remain weak as the top-line is expected to be pressured by the weak international patient outlook. Although BH should be fairly immune to copayment, the weak outlook for top-line growth is likely to persist. We expect the 1Q25 outlook to remain weak, as Ramadan this year will fall entirely in 1Q25, negatively impacting BH's earnings. Maintain BUY. Target price: Bt232.00.

Benjaphol Suthwanish ... (+2)
  • Benjaphol Suthwanish
  • Kasemsun Koonnara

Thailand Daily - Friday, February 14, 2025

KEY HIGHLIGHTS Update Bumrungrad Hospital (BH TB/BUY/Bt175.50/Target: Bt232.00) Weak 4Q24 earnings expected. Central Plaza Hotel (CENTEL TB/BUY/Bt28.00/Target: Bt33.00) Reaching a turning point; upgrade to BUY. Central Pattana (CPN TB/BUY/Bt52.25/Target: Bt79.30) Expect 4Q24 earnings to be pressured by SG&A, but 2024 is set to deliver a record profit.

Bella Lu Yifei ... (+13)
  • Bella Lu Yifei
  • Benjaphol Suthwanish
  • Carol Dou Xiao Qin
  • Chong Lee Len
  • Colin Lee
  • Heidi Mo Jinghui
  • John Cheong Ming Chern
  • Johnny Yum Chung Man
  • Jonathan Koh
  • Kasemsun Koonnara
  • Ken Lee
  • Stevanus Juanda
  • Sunny Chen

Regional Morning Meeting Notes: Friday, February 14, 2025

GREATER CHINA Sector Automobile Weekly: PV sales stay low, BYD to equip all EVs with DiPilot ADAS. Upgrade BYD to BUY. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely, CATL, Fuyao and Desay. Update AAC Technologies (2018 HK/HOLD/HK$46.55/ Target: HK$48.00) 2024 profit alert – earnings set to beat expectations. Maintain HOLD. The United Laboratories International (3933 HK/HOLD/HK$12.42/Target: H...

Jonathan Koh ... (+8)
  • Jonathan Koh
  • Philip Wong
  • Posmarito Pakpahan
  • Shirley Wang Xueyi
  • Singapore Research Team
  • Stella Guo Yuting
  • Tham Mun Hon
  • Thanawat Thangchadakorn

Regional Morning Meeting Notes: Thursday, January 02, 2025

GREATER CHINA Economics PMI A strong rebound for non-manufacturing PMI. Sector Macau Gaming Dec 24 GGR below expectations; expect 2025 GGR to recover to 82% of 2019’s level. INDONESIA Update Mitra Keluarga Karyasehat (MIKA IJ/BUY/Rp2,540/Target: Rp3,300) Expect a double-digit earnings growth in 2025 MALAYSIA Sector Heal...

BDMS BANGKOK DUSIT MEDICAL SERVICES
KKP KIATNAKIN BANK
OU8 CENTURION
FCT FRASERS CENTREPOINT TRUST
5225 IHH HEALTHCARE BHD.
BBL BANGKOK BANK PUBLIC COMPANY LIMITED
544 CSE GLOBAL LTD.
7090 APEX HEALTHCARE
KTB KRUNG THAI BANK PUBLIC CO. LTD.
V03 VENTURE CORPORATION LIMITED
U96 SEMBCORP INDUSTRIES LTD.
B8O YANGZIJIANG SHIPBUILDING (HOLDINGS) LTD.
TISCO TISCO FINANCIAL GROUP
N2IU MAPLETREE COMMERCIAL TRUST
AJBU KEPPEL DC REIT
BUOU FRASERS LOGISTICS & COMMERCIAL TRUST
00027 GALAXY ENTERTAINMENT GROUP LIMITED
TMB TMB BANK PUBLIC COMPANY LIMITED
KBANK KASIKORNBANK PUBLIC CO. LTD.
C61U CAPITALAND COMMERCIAL TRUST
BH BUMRUNGRAD HOSPITAL PUBLIC CO. LTD.
O39 OVERSEA-CHINESE BANKING CORPORATION LIMITED
599A SANDS CHINA LTD.
BCH BANGKOK CHAIN HOSPITAL PCL
Q5T FAR EAST HOSPITALITY TRUST
MIKA MITRA KELUARGA KARYASEHAT
SATS SP SATS LTD.
G13 GENTING SINGAPORE LIMITED
CDREIT CDL HOSPITALITY TRUSTS
KREIT KEPPEL REIT
MLT MAPLETREE LOGISTICS TRUST
PREIT PARKWAYLIFE REAL ESTATE
KPJ KPJ HEALTHCARE BERHAD
MINT MAPLETREE INDUSTRIAL TRUST
RFMD RAFFLES MEDICAL GROUP LTD
SASSR SASSEUR REAL ESTATE INVESTMENT TRUST
TXG 10X GENOMICS INC CLASS A
DBB DUOPHARMA BIOTECH BHD
TGIF 1933 INDUSTRIES
ELITE ELITE COMMERCIAL REIT
UHU UNITED HAMPSHIRE US REIT
MPM MARCO POLO MARINE LTD
CSSC CHINA SUNSINE CHEMICAL HOLDINGS LTD
LREIT SP LENDLEASE GLOBAL COMMERCIAL REIT
OXMU PRIME US REIT
HMN ASCOTT RESIDENCE TRUST
CLCT CAPITALAND CHINA TRUST
KORE KEPPEL PACIFIC OAK US REIT
AMOKD 3DX INDUSTRIES INC
CVL CIVMEC
TSVT 2SEVENTY BIO INC
SCB SCB X PUBLIC COMPANY LIMITED
BCOW 1895 BANCORP OF WISCONSIN INC
CLAR CAPITALAND ASCENDAS REIT
AL2SI 2CRSI SA
DCRU DIGITAL CORE REIT MANAGEMENT PTE. LTD.
STM SEATRIUM LTD
Z29 029 GROUP SE
0303 ALPHA IVF GROUP

Bumrungrad Hospital Public Company Limited: 1 director

A director at Bumrungrad Hospital Public Company Limited sold 100,000 shares at 199.000THB and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

Benjaphol Suthwanish
  • Benjaphol Suthwanish

Bumrungrad Hospital (BH TB) - 3Q24: Disappointing Earnings Despite Hig...

BH reported a net profit of Bt1.96b in 3Q24 (+0.0% yoy, +1.2% qoq) which disappointed the market due to lower-than-expected revenue. Revenue from both Thai and foreign patients declined yoy. We believe that in the long term, BH still has strong fundamentals as construction of its new hospital in Phuket has already started and capacity expansion at the main campus is underway. Maintain BUY. Target price: Bt303.00.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch